Pharmabiz12h
icometrix’s AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment
AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...
The i on MSN13h
Fact or fiction? The science behind RFK Jr’s health stances
Doctors are most concerned about the new US Health Secretary's unwarranted criticisms of vaccine safety - here his other ...
MedPage Today23h
FDA Approves First Menin Inhibitor for Acute Leukemia
The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...
FDA approves Syndax’s Revuforj for acute leukemia
The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
precisionmedicineonline22h
Syndax's Revuforj Garners FDA Approval for Refractory KMT2A-Altered Acute Leukemia
NEW YORK – The US Food and Drug Administration on Friday approved Syndax Pharmaceuticals' Revuforj (revumenib ... and if they're simultaneously prescribed CYP3A4 inhibitors, the FDA said in a ...